SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133989
Filing Date
2022-04-29
Accepted
2022-04-29 16:35:43
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d276398ddefa14a.htm DEFA14A 23448
2 GRAPHIC g276398g33s33.jpg GRAPHIC 16870
3 GRAPHIC g276398g34s34.jpg GRAPHIC 10496
4 GRAPHIC g276398g35s35.jpg GRAPHIC 11155
5 GRAPHIC g276398g36s36.jpg GRAPHIC 10969
6 GRAPHIC g276398g37s37.jpg GRAPHIC 9767
7 GRAPHIC g276398g38s38.jpg GRAPHIC 15762
8 GRAPHIC g276398g39s39.jpg GRAPHIC 10798
  Complete submission text file 0001193125-22-133989.txt   142558
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39062 | Film No.: 22876315
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences